Viewing Study NCT03673995



Ignite Creation Date: 2024-05-06 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 12:54 PM
Study NCT ID: NCT03673995
Status: COMPLETED
Last Update Posted: 2020-06-16
First Post: 2018-08-22

Brief Title: Myoinositol Plus L-tyrosine Selenium and Chromium in PCOS
Sponsor: Pharmarte srl
Organization: Pharmarte srl

Study Overview

Official Title: Use of Myoinositol Plus L-tyrosine Selenium and Chromium in PCOS Women
Status: COMPLETED
Status Verified Date: 2018-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: PCOS patients were treated every day with one sachet containing 2000 mg myo-inositol 500 mg L-tyrosine 40 mcg chromium picolinate 55 mcg selenium 200 mcg folic acid All patients underwent before starting the therapy after 3 months and 6 months hormonal evaluation hirsutism scoring and ovulation assesment Most of them during the treatment improved their symptoms
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None